Patanjali Ayurveda

Patanjali Foods Ltd has recalled 4 tonnes of red chilli powder from markets following the direction from food regulator FSSAI. The Food Safety and Standards Authority of India (FSSAI) asked Patanjali Foods to recall a specified batch of packed red chilli powder due to non-conformity with food safety norms. "Patanjali Foods has recalled small batch of 4 tonnes of 'Red Chilli Powder (200 gram pack)," the company's CEO Sanjeev Asthana said in a statement. "The product sample when tested were found not conforming to the maximum permitted limit of pesticides residue. The FSSAI sets Maximum Residue Limits (MRLs) for pesticides residue for various food items including red chilli powder," he said. In line with specified regulatory norms, Asthana said the company has taken immediate steps to inform its distribution channel partners and also released advertisements to reach out to the consumers who have purchased the product. He urged customers to return the product to the place of purchase

The lawsuit alleges that an advertisement featuring Patanjali Ayurved founder Baba Ramdev falsely claims that only Patanjali's Chyawanprash is 'original'

The Competition Commission of India (CCI) on Tuesday cleared the proposed acquisition of the home and personal care business of Patanjali Ayurved by Patanjali Foods in a Rs 1,100 crore deal. "The proposed combination involves the acquisition of Patanjali Ayurved Ltd's (PAL) Home and Personal Care (HPC) business division (nonfood business) by Patanjali Foods Ltd (PFL)," the CCI said in a release. Patanjali Foods is engaged in processing of oilseeds, refining of crude oil for edible use, production of oil meal, food products from soya and value-added products from downstream and upstream processing. It is also engaged in the business of fast-moving consumer goods, fast moving health goods comprising mainly of food, biscuits and nutraceutical products and engaged in generation of power from wind energy and trading in various products. Patanjali Ayurved is engaged in the business of manufacturing, trading, packing and labelling of ayurvedic medicines, HPC items such as dairy items and

Patanjali Foods share price: Reports said Promoter entities Patanjali Ayurved, and Patanjali Parivahan were looking to sell up to 11 million shares in the company

The court is hearing a petition filed by the Indian Medical Association (IMA) against Patanjali's advertisements attacking allopathy and making claims about curing certain diseases

A case in this regard was registered in 2021 after reports found the samples did not meet the food safety standards

SC had recently criticised Ramdev for not complying with its directives in an ongoing lawsuit to stop misleading advertisements of some of his traditional ayurvedic medicines

Ramdev says he would publish a bigger apology in newspapers; court adjourns matter for a week

Though Ramdev and Balkrishna tendered apologies for their actions, the SC Bench hinted that their apology wasn't sufficient to absolve them of responsibility

Patanjali Ayurved founder Ramdev and MD Balkrishna have submitted affidavits offering 'unconditional, unqualified' apologies to the Supreme Court

Where does the buck stop after SC rap on Patanjali? Can Blinkit challenge Amazon & Flipkart? Why did Vodafone Idea's fundraise plan fail? What is the Carbon Border Adjustment Mechanism? Answers here

The government has provided a one-time exemption from the export ban to Patanjali Ayurved for shipping 20 tonnes of non-basmati white rice as a donation to Nepal for earthquake victims. Though exports of non-basmati white rice were banned on July 20 to boost domestic supply, exports are allowed on the basis of permission granted by the government to certain countries to meet their food security needs and on request. "One time exemption from prohibition is granted to Patanjali Ayurved Ltd for export of 20 MT of Non-basmati white rice (Semi-milled or wholly milled rice, whether or not polished or glazed)as donation to Nepal for earthquake victims," the directorate general of foreign trade (DGFT) has said in a notification. According to a DGFT's notification issued in October, the government permitted exports of 10,34,800 tonnes of non-basmati white rice to seven countries, including Nepal, Cameroon and Malaysia. The quantity notified for Nepal is 95,000 tonnes, Cameroon (1,90,000 ...

Stocks to watch on July 14, 2023: Bandhan Bank, JSW Energy, Just Dial and Kesoram Industries among prominent firms scheduled to announce June quarter earnings on Friday.

The floor price for the 'Offer for Sale' was fixed at Rs 1,000 per equity share; and the offer will be on July 13 and 14.

Share sale will help company meet minimum public shareholding (MPS) requirement

Patanjali Group is looking to clock a turnover of Rs 1 lakh crore in next five years as it expands reach to all sections of consumers with different offerings, its leader Baba Ramdev said on Friday. Group firm Patanjali Foods (previously Ruchi Soya) will also play a significant part in achieving the milestone, having set a target of Rs 45,000-50,000 crore turnover in next five years. As part of its portfolio premiumisation strategy, Patanjali Foods introduced a new range of offerings in nutraceuticals, health biscuits, Nutrela millet-based cereals, and dry fruits. "It is our vision to take the turnover of Patanjali Group to Rs 1 lakh crore in next 5 years and that of Patanjali Foods, which is our listed company to up to Rs 50,000 crore," Ramdev said while addressing a press conference here. Patanjali has been focussing on self reliance in India, challenging the multinationals in the domestic market, he said adding,"Today we have overtaken all the MNCs except Unilever, which is stil

Patanjali is strengthening its distribution system by expanding it from the current one million outlets to about 1.5 million outlets

Move follows sustained dip in FPI holding in the counter; IDBI Bank, Patanjali among other stocks to get in

At the upper end, Patanjali, which now owns 98.9 per cent of the company, will dilute around 19 per cent and 18 per cent at the lower end of the price band

Pandemic delays therapy for eye diseases, Patanjali's Coronil makes a comeback, cherry-picking of Covid vaccination figures, and more-news relevant to India's fight against Covid-19